Accrued expenses and other current liabilities

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Accrued expenses and other current liabilities

Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	As of December 31,
	2023		2022
Accrued expenses and other current liabilities:
Accrued research and development	$	11,243	$	9,824
Accrued compensation and benefits	7,344		6,831
Other	2,043		3,114
Total accrued expenses and other current liabilities	$	20,630	$	19,769

As of December 31, 2023 there were $3.1 million of costs related to wind down activities for CFT8634 included within the accrued research and development balance.